Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
AUC |
52.8 |
ng.h/ml |
52.82 |
ng.h/ml |
PO, oral; |
DRUGBANK |
Bioavailability |
30.0 |
% |
30 |
% |
PO, oral; fasting; |
DRUGBANK |
Bioavailability |
67.5 |
% |
60-75 |
% |
PO, oral; food; |
DRUGBANK |
Css |
4790.0 |
ng/ml |
4.79 |
mg/L |
|
DRUGBANK |
T Max |
4.0 |
h |
3-5 |
h |
PO, oral; fasting; |
DRUGBANK |
T Max |
5.5 |
h |
3-8 |
h |
PO, oral; food; |
DRUGBANK |
T Max |
4.5 |
h |
3-6 |
h |
PO, oral; |
DRUGBANK |
T Max |
4.0 |
h |
4 |
h |
PO, oral; |
DRUGBANK |
Clearance |
7.0 |
L/h |
116.0 |
ml/min |
|
DRUGBANK |
Volume of Distribution |
119.0 |
L |
119.0 |
L |
Apparent volume of distribution; intravenous injection, IV; |
DRUGBANK |
Half-life |
20.0 |
h |
~20 |
h |
|
DRUGBANK |
Half-life |
20.0 |
h |
~20 |
h |
Active metabolite; |
DRUGBANK |
Half-life |
12.5 |
h |
10-15 |
h |
terminal half-life; different study; |
DRUGBANK |
Eliminate Route |
63.4 |
% |
63.4 |
% |
Urinary excretion; PO, oral; |
DRUGBANK |
Eliminate Route |
32.4 |
% |
32.4 |
% |
Faeces excretion; PO, oral; |
DRUGBANK |
Eliminate Route |
4.4 |
% |
4.43 |
% |
Urinary excretion; PO, oral; Unchanged drug; |
DRUGBANK |
Eliminate Route |
9.7 |
% |
9.72 |
% |
Faeces excretion; PO, oral; Unchanged drug; |
DRUGBANK |
Protein Binding |
92.0 |
% |
92 |
% |
plasma proteins; |
DRUGBANK |